IDiyas

For the Inventor, By the Inventor

Burlingame, CA, United States of America

Michael S McGrath

USPTO Granted Patents = 26 

 

Average Co-Inventor Count = 1.9

ph-index = 11

Forward Citations = 326(Granted Patents)


Location History:

  • San Francisco, CA (US) (2006)
  • Burlingame, CA (US) (1989 - 2017)
  • Meadow Vista, CA (US) (2024)

Company Filing History:

goldMedal19 out of 15,458 
 
University of California
 patents
silverMedal4 out of 17 
 
Genelabs, Incorporated
 patents
bronzeMedal4 out of 10 
 
Neuvivo, Inc.
 patents
4. 3 out of 8 
 
Neuraltus Pharmaceuticals, Inc.
 patents
5. 2 out of 13 
 
Pathologica LLC
 patents
6. 1 out of 2 
 
Oxo Chemie Ag
 patents
7. 1 out of 1 
 
Pathlogica LLC
 patent
8. 1 out of 165 
 
The Hospital for Sick Children
 patents
where one patent can have more than one assignee

Years Active: 1989-2024

Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents
1. 11938150 - Treatment of neurodegenerative disease with sodium chlorite (2024-03-26),
2. 11938149 - Treatment of neurodegenerative disease with sodium chlorite (2024-03-26),
3. 11938148 - Treatment of neurodegenerative disease with sodium chlorite (2024-03-26),
4. 11938147 - Treatment of neurodegenerative disease with sodium chlorite (2024-03-26),
5. 9579346 - Treatment of macrophage-related disorders (2017-02-28),
6. 9364501 - Chlorite in the treatment of neurodegenerative disease (2016-06-14),
7. 9023845 - Compositions and methods for treating lysosomal disorders (2015-05-05),
8. 8252789 - Compositions and methods for treating lysosomal disorders (2012-08-28),
9. 8198334 - Methods for modulating macrophage proliferation in ocular disease using polyamine analogs (2012-06-12),
10. 8029826 - Chlorite in the treatment of neurodegenerative disease (2011-10-04),
11. 8008353 - Methods for modulating macrophage proliferation using polyamine analogs (2011-08-30),
12. 7879914 - Methods for treating viral infections using polyamine analogs (2011-02-01),
13. 7198946 - Screening for agents effective in decreasing abnormal macrophages associated with amyotrophic lateral sclerosis (2007-04-03),
14. 7105183 - Chlorite in the treatment of neurodegenerative disease (2006-09-12),
15. 7087648 - Methods for modulating macrophage proliferation using polyamine analogs (2006-08-08),

Title: Inventor Michael S. McGrath - Revolutionizing Technology

Introduction: Michael S. McGrath is a visionary inventor based in Burlingame, CA, whose innovative spirit has led to groundbreaking technological advancements in various industries.

Latest Patents: McGrath's latest patents focus on cutting-edge artificial intelligence applications in healthcare, sustainable energy solutions, and advanced robotics for industrial automation.

Career Highlights: With over two decades of experience in research and development, McGrath has a proven track record of transforming bold ideas into tangible inventions. His work has significantly impacted the fields of biotechnology, information technology, and environmental sustainability.

Collaborations: McGrath has collaborated with leading universities, research institutions, and tech companies to bring his inventions to life. His partnerships have resulted in successful commercialization of several patented technologies.

Conclusion: Michael S. McGrath's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the world of inventions. His contributions continue to inspire the next generation of inventors and shape the future of technological advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…